Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Renal Involvement in H Syndrome, A Rare Cause of Diabetes Mellitus: Case Report

Author(s): Recep Polat*, Ala Ustyol, Rabia Altunbaş and Serdar Ceylaner

Volume 23, Issue 5, 2023

Published on: 27 December, 2022

Page: [727 - 731] Pages: 5

DOI: 10.2174/1871530323666221111151455

Price: $65

Abstract

Background: H syndrome is a rare genodermatosis deriving from a mutation in the SLC29A3 gene and affecting numerous systems, particularly the skin. The syndrome exhibits different clinical characteristics involving several systems, most beginning with the letter "H." The most common clinical findings are cutaneous hyperpigmentation, flexion contracture in the fingers, hearing loss, short stature, insulin-dependent diabetes mellitus, heart anomalies, hepatosplenomegaly, and hypogonadism. Fewer than 150 cases have been reported so far and vast majority of them consisted with patients with Arab ethnicity.

Case Presentation: We describe a patient presenting with short stature, developing diabetes mellitus at follow-ups, with homozygous deletion determined in exon 3 of the SLC29A3 gene, and diagnosed with H syndrome, reported due to the presence and rarity of renal involvement (hematuria and proteinuria).

Conclusion: In conclusion, despite its rarity, endocrinologists, rheumatologists/nephrologists, and dermatologists need to be aware of H syndrome as a pleiotropic syndrome. H syndrome should be considered in the differential diagnosis of patients with cutaneous hyperpigmentation (particularly in the bilateral thigh and calf region) together with proteinuria/hematuria. In addition, periodic urine analysis should be performed in patients with H syndrome.

« Previous Next »
Graphical Abstract

[1]
Sybert, V.P. Disorders of the Pigmentation. In: Genetic Skin Disorders, 3rd ed; Sybert, V.P., Ed.; Oxford University Press: New York, 2017; pp. 173-219.
[http://dx.doi.org/10.1093/med/9780190276478.001.0001]
[2]
Moynihan, L.M.; Bundey, S.E.; Heath, D.; Jones, E.L.; McHale, D.P.; Mueller, R.F.; Markham, A.F.; Lench, N.J. Autozygosity mapping, to chromosome 11q25, of a rare autosomal recessive syndrome causing histiocytosis, joint contractures, and sensorineural deafness. Am. J. Hum. Genet., 1998, 62(5), 1123-1128.
[http://dx.doi.org/10.1086/301824] [PMID: 9545394]
[3]
Molho, P.V.; Ramot, Y.; Camille, F.; Doviner, V.; Babay, S.; Luis, S.J.; Broshtilova, V.; Zlotogorski, A. H syndrome: The first 79 patients. J. Am. Acad. Dermatol., 2014, 70(1), 80-88.
[http://dx.doi.org/10.1016/j.jaad.2013.09.019] [PMID: 24172204]
[4]
Avitan, H.E.; Mandel, H.; Indelman, M.; Bar, J.G.; Zlotogorski, A.; Bergman, R. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease. Am. J. Dermatopathol., 2011, 33(1), 47-51.
[http://dx.doi.org/10.1097/DAD.0b013e3181ee547c] [PMID: 21178579]
[5]
Emile, J.F.; Abla, O.; Fraitag, S.; Horne, A.; Haroche, J.; Donadieu, J.; Requena, C.L.; Jordan, M.B.; Abdel, W.O.; Allen, C.E.; Charlotte, F.; Diamond, E.L.; Egeler, R.M.; Fischer, A.; Herrera, J.G.; Henter, J.I.; Janku, F.; Merad, M.; Picarsic, J.; Rodriguez, G.C.; Rollins, B.J.; Tazi, A.; Vassallo, R.; Weiss, L.M. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood, 2016, 127(22), 2672-2681.
[http://dx.doi.org/10.1182/blood-2016-01-690636] [PMID: 26966089]
[6]
Lapeere, H.; Boone, B.; De Schepper, S.; Verhaeghe, E.; Van Geel, M.; Ongenae, K.; Van Geel, N.; Lambert, J.; Brochez, L. Hypomelanoses and hypermelanoses. In: Fitzpatrick’s Dermatology in General Medicine, 8th ed; Wolff, K.; Goldsmith, L.A.; Katz, S.I.; Gilchrest, B.A.; Paller, A.S.; Leffell, D.J., Eds.; McGraw-Hill Medical: New York, 2012; 1, pp. 804-826.
[7]
Mavropoulos, J.C.; Cohen, B.A. Pigmentation disorders. In: Pediatric Dermatology E-Book, 4th ed; Cohen, B.A., Ed.; Elsevier Health Sciences: China, 2013; pp. 148-168.
[http://dx.doi.org/10.1016/B978-0-7234-3655-3.00006-0]
[8]
El-Bassyouni, H.T.; Thomas, M.M.; Tosson, A.M.S. Mutation in the SLC29A3 gene in an Egyptian patient with H syndrome: A case report and review of literature. J. Pediatr. Genet., 2020, 9(2), 109-113.
[http://dx.doi.org/10.1055/s-0039-1697900] [PMID: 32341814]
[9]
David, O.; Geylis, M.; Kristal, E.; Ling, G.; Schreiber, R. Glomerular involvement in children with H syndrome. Pediatr. Nephrol., 2021, 36(3), 721-724.
[http://dx.doi.org/10.1007/s00467-020-04860-5] [PMID: 33387019]
[10]
KDlGO. Chapter 7: Idiopathic membranous nephropathy. Kidney Int. Suppl., 2011, 2(2), 186-197.
[http://dx.doi.org/10.1038/kisup.2012.20]
[11]
Morgan, N.V.; Morris, M.R.; Cangul, H.; Gleeson, D.; Iwanowska, A.; Davies, N.; Keenan, S.; Pasha, S.; Rahman, F.; Gentle, D.; Vreeswijk, M.P.; Devilee, P.; Knowles, M.A.; Ceylaner, S.; Trembath, R.C.; Dalence, C.; Kismet, E.; Köseoğlu, V.; Rossbach, H.C.; Gissen, P.; Tannahill, D.; Maher, E.R Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (faisalabad histiocytosis) and familial rosai-dorfman disease. PLoS Genet., 2010, 6(2), e1000833.
[http://dx.doi.org/10.1371/journal.pgen.1000833]
[12]
Ozlu, C.; Yesiltepe, M.G.; Hatun, S. A Turkish girl with H syndrome: Stunted growth and development of autoimmune insulin dependent diabetes mellitus in the 6th year of diagnosis. J. Pediatr. Endocrinol. Metab., 2019, 32(1), 89-93.
[http://dx.doi.org/10.1515/jpem-2018-0380]
[13]
Cliffe, S.T.; Kramer, J.M.; Hussain, K.; Robben, J.H.; De Jong, E.K.; De Brouwer, A.P.; Nibbeling, E.; Kamsteeg, E.J.; Wong, M.; Prendiville, J.; James, C.; Padidela, R.; Becknell, C.; Van Bokhoven, H.; Deen, P.M.T.; Hennekam, R.C.M.; Lindeman, R.; Schenck, A.; Roscioli, T.; Buckley, M.F. SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Hum. Mol. Genet., 2009, 18(12), 2257-2265.
[http://dx.doi.org/10.1093/hmg/ddp161] [PMID: 19336477]
[14]
Molnar, C.; López, V.A.; Hernández, R.; De Celis, J.F. A gain-of-function screen identifying genes required for vein formation in the Drosophila melanogaster wing. Genetics, 2006, 174(3), 1635-1659.
[http://dx.doi.org/10.1534/genetics.106.061283] [PMID: 16980395]
[15]
Hsu, C.L.; Lin, W.; Seshasayee, D.; Chen, Y.H.; Ding, X.; Lin, Z.; Suto, E.; Huang, Z.; Lee, W.P.; Park, H.; Xu, M.; Sun, M.; Rangell, L.; Lutman, J.L.; Ulufatu, S.; Stefanich, E.; Chalouni, C.; Sagolla, M.; Diehl, L.; Fielder, P.; Dean, B.; Balazs, M.; Martin, F. Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science, 2012, 335(6064), 89-92.
[http://dx.doi.org/10.1126/science.1213682] [PMID: 22174130]
[16]
Doviner, V.; Maly, A.; Ne’eman, Z.; Qawasmi, R.; Aamar, S.; Sultan, M.; Spiegel, M.; Molho, P.V.; Zlotogorski, A. H syndrome: Recently defined genodermatosis with distinct histologic features. A morphological, histochemical, immunohistochemical, and ultrastructural study of 10 cases. Am. J. Dermatopathol., 2010, 32(2), 118-128.
[http://dx.doi.org/10.1097/DAD.0b013e3181b28572] [PMID: 20010285]
[17]
Simsek, E.; Simsek, T.; Eren, M.; Yilmaz, E.; Arik, D.; Cilingir, O.; Ceylaner, S.; Harmancı,, K. Clinical, histochemical, and molecular study of three turkish siblings diagnosed with H syndrome, and literature review. Horm. Res. Paediatr., 2019, 91(5), 346-355.
[http://dx.doi.org/10.1159/000495190] [PMID: 30625464]
[18]
Behrangi, E.; Sadeghzadeh, B.A.; Khosravi, S.; Shemshadi, M.; Youssefian, L.; Vahidnezhad, H.; Goodarzi, A.; Uitto, J. Mycophenolate mofetil treatment of an H syndrome patient with a SLC29A3 mutation. Dermatol. Ther., 2020, 33(6), e14375.
[http://dx.doi.org/10.1111/dth.14375] [PMID: 33029882]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy